IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CUONG D NGUYEN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1659497451
CMS profile
166134
Location
NORMAN, OK

General Payments · PY2018–2024

$1,905.49

  • Reported across 104 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,001.91

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology OK All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $931.27 50
Education $70.64 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $309.80 13
Retrophin, Inc. $260.90 18
Amgen Inc. $167.14 11
Ardelyx, Inc. $55.74 3
Otsuka America Pharmaceutical, Inc. $49.23 3
GlaxoSmithKline, LLC. $43.42 2
Novo Nordisk AS $42.27 2
Lilly USA, LLC $27.75 1
Otsuka Pharmaceutical Development & Commercialization, Inc. $27.53 1
Bayer HealthCare Pharmaceuticals Inc. $18.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $296.33 20
PY2019 $96.02 7
PY2020 $28.13 2
PY2021 $42.32 3
PY2022 $66.01 4
PY2023 $374.77 13
PY2024 $1,001.91 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.31 02/07/2024 Food and Beverage Undisputed 01/23/2026 1117339379 CMS
Amgen Inc. $14.06 04/30/2024 Food and Beverage Undisputed 01/23/2026 1117339381 CMS
Amgen Inc. $14.26 06/19/2024 Food and Beverage Undisputed 01/23/2026 1117339383 CMS
Amgen Inc. $22.66 07/26/2024 Food and Beverage Undisputed 01/23/2026 1111661937 CMS
Amgen Inc. $4.58 08/27/2024 Food and Beverage Undisputed 01/23/2026 1111661939 CMS
Amgen Inc. $18.62 09/10/2024 Food and Beverage Undisputed 01/23/2026 1111661941 CMS
Amgen Inc. $14.13 09/11/2024 Food and Beverage Undisputed 01/23/2026 1117339385 CMS
Amgen Inc. $11.19 10/08/2024 Food and Beverage Undisputed 01/23/2026 1117339387 CMS
Amgen Inc. $13.38 10/16/2024 Food and Beverage Undisputed 01/23/2026 1111661943 CMS
Amgen Inc. $23.19 11/14/2024 Food and Beverage Undisputed 01/23/2026 1111661945 CMS
Amgen Inc. $13.76 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117339389 CMS
Ardelyx, Inc. $15.31 06/18/2024 Food and Beverage Undisputed 01/23/2026 1146697828 CMS
Ardelyx, Inc. $20.01 08/15/2024 Food and Beverage Undisputed 01/23/2026 1146697830 CMS
Ardelyx, Inc. $20.42 11/07/2024 Food and Beverage Undisputed 01/23/2026 1146697832 CMS
AstraZeneca Pharmaceuticals LP $77.16 01/10/2024 Food and Beverage Undisputed 01/23/2026 1104312908 CMS
AstraZeneca Pharmaceuticals LP $16.23 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105295665 CMS
AstraZeneca Pharmaceuticals LP $20.40 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105771994 CMS
AstraZeneca Pharmaceuticals LP $21.21 06/25/2024 Food and Beverage Undisputed 01/23/2026 1104637501 CMS
AstraZeneca Pharmaceuticals LP $14.31 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105651102 CMS
AstraZeneca Pharmaceuticals LP $17.10 08/13/2024 Food and Beverage Undisputed 01/23/2026 1104280077 CMS
AstraZeneca Pharmaceuticals LP $16.34 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104662733 CMS
AstraZeneca Pharmaceuticals LP $18.58 09/12/2024 Food and Beverage Undisputed 01/23/2026 1104450408 CMS
AstraZeneca Pharmaceuticals LP $14.95 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104270889 CMS
AstraZeneca Pharmaceuticals LP $17.90 09/17/2024 Food and Beverage Undisputed 01/23/2026 1105893958 CMS
AstraZeneca Pharmaceuticals LP $21.45 10/10/2024 Food and Beverage Undisputed 01/23/2026 1104292088 CMS
AstraZeneca Pharmaceuticals LP $24.90 11/06/2024 Food and Beverage Undisputed 01/23/2026 1105612867 CMS
AstraZeneca Pharmaceuticals LP $29.27 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104307760 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.13 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086190976 CMS
GlaxoSmithKline, LLC. $19.08 03/28/2024 Food and Beverage Undisputed 01/23/2026 1116703116 CMS
GlaxoSmithKline, LLC. $24.34 11/12/2024 Food and Beverage Undisputed 01/23/2026 1115853182 CMS
Lilly USA, LLC $27.75 08/12/2024 Food and Beverage Undisputed 01/23/2026 1136121750 CMS
Novo Nordisk Inc $21.16 08/21/2024 Food and Beverage Undisputed 01/23/2026 1097681232 CMS
Novo Nordisk Inc $21.11 12/04/2024 Food and Beverage Undisputed 01/23/2026 1096793554 CMS
Otsuka America Pharmaceutical, Inc. $20.86 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118950806 CMS
Otsuka America Pharmaceutical, Inc. $13.57 08/22/2024 Food and Beverage Undisputed 01/23/2026 1118950808 CMS
Otsuka America Pharmaceutical, Inc. $14.80 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118950810 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $27.53 07/15/2024 Food and Beverage Undisputed 01/23/2026 1118838685 CMS
Travere Therapeutics, Inc. $5.27 02/16/2024 Food and Beverage Undisputed 01/23/2026 1149926031 CMS
Travere Therapeutics, Inc. $16.89 03/12/2024 Education Undisputed 01/23/2026 1149926051 CMS
Travere Therapeutics, Inc. $28.05 03/12/2024 Food and Beverage Undisputed 01/23/2026 1149926071 CMS
Travere Therapeutics, Inc. $3.08 03/26/2024 Education Undisputed 01/23/2026 1149926016 CMS
Travere Therapeutics, Inc. $16.89 03/26/2024 Education Undisputed 01/23/2026 1149926055 CMS
Travere Therapeutics, Inc. $25.64 03/26/2024 Food and Beverage Undisputed 01/23/2026 1149926067 CMS
Travere Therapeutics, Inc. $8.03 04/03/2024 Food and Beverage Undisputed 01/23/2026 1149926047 CMS
Travere Therapeutics, Inc. $5.32 04/22/2024 Food and Beverage Undisputed 01/23/2026 1149926035 CMS
Travere Therapeutics, Inc. $5.12 05/09/2024 Food and Beverage Undisputed 01/23/2026 1149926024 CMS
Travere Therapeutics, Inc. $30.82 06/11/2024 Food and Beverage Undisputed 01/23/2026 1149926079 CMS
Travere Therapeutics, Inc. $5.23 07/09/2024 Food and Beverage Undisputed 01/23/2026 1149926027 CMS
Travere Therapeutics, Inc. $16.89 08/19/2024 Education Undisputed 01/23/2026 1149926059 CMS
Travere Therapeutics, Inc. $5.83 08/20/2024 Food and Beverage Undisputed 01/23/2026 1149926039 CMS
Travere Therapeutics, Inc. $16.89 09/03/2024 Education Undisputed 01/23/2026 1149926063 CMS
Travere Therapeutics, Inc. $30.56 09/13/2024 Food and Beverage Undisputed 01/23/2026 1149926075 CMS
Travere Therapeutics, Inc. $31.10 09/24/2024 Food and Beverage Undisputed 01/23/2026 1149926083 CMS
Travere Therapeutics, Inc. $3.45 10/21/2024 Food and Beverage Undisputed 01/23/2026 1149926020 CMS
Travere Therapeutics, Inc. $5.84 12/09/2024 Food and Beverage Undisputed 01/23/2026 1149926043 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.